go to medicines.ie homepage
  • Home  |  
  • About  |  
  • Links  |  
  • Help
Font Size
Search for:  
select
select
  • SPCs and PILs
  • SPCs Only
  • PILs Only
  Advanced Search
  • What's
    New
      
  • Browse
    Medicines
      
  • Browse
    Active Ingredients
      
  • Browse
    Companies
      
  • Codes
    of Practice
      
  • Adverse
    Reaction Reporting

Alliance Pharmaceuticals Ireland

Alliance Pharmaceuticals Ireland
United Drug House, Magna Drive, Magna Business Park, Citywest Road, Dublin 24, Ireland
Telephone: + 44 (0)1249 466966
Fax: +44 (0)1249 466 977
Medical Information e-mail: medinfo@alliancepharma.co.uk


Summary of Product Characteristics last updated on medicines.ie: 16/08/2010
SPC Aquadrate 10% w/w Cream

Table of Contents

  • 1. NAME OF THE MEDICINAL PRODUCT
  • 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
  • 3. PHARMACEUTICAL FORM
  • 4. CLINICAL PARTICULARS
  • 4.1 Therapeutic indications
  • 4.2 Posology and method of administration
  • 4.3 Contraindications
  • 4.4 Special warnings and precautions for use
  • 4.5 Interaction with other medicinal products and other forms of interaction
  • 4.6 Pregnancy and lactation
  • 4.7 Effects on ability to drive and use machines
  • 4.8 Undesirable effects
  • 4.9 Overdose
  • 5. PHARMACOLOGICAL PROPERTIES
  • 5.1 Pharmacodynamic properties
  • 5.2 Pharmacokinetic properties
  • 5.3 Preclinical safety data
  • 6. PHARMACEUTICAL PARTICULARS
  • 6.1 List of excipient(s)
  • 6.2 Incompatibilities
  • 6.3 Shelf life
  • 6.4 Special precautions for storage
  • 6.5 Nature and contents of container
  • 6.6 Special precautions for disposal and other handling
  • 7. MARKETING AUTHORISATION HOLDER
  • 8. MARKETING AUTHORISATION NUMBER(S)
  • 9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
  • 10. DATE OF REVISION OF THE TEXT


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Aquadrate 10% w/w Cream.


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Aquadrate cream contains Urea 10% w/w

For a full list of excipients, see section 6.1.


Go to top of the page
3. PHARMACEUTICAL FORM

Cream

A smooth, unperfumed, non-greasy, off-white cream for topical administration.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

For the management of ichthyosis, xeroderma, hyperkeratosis and other chronic dry skin conditions.


Go to top of the page
4.2 Posology and method of administration

Aquadrate is applied topically. Wash affected areas well, rinse off all traces of soap, dry, and apply sparingly twice daily. Occlusive dressings may be used but are usually unnecessary because of the self-occlusive nature of the cream.


Go to top of the page
4.3 Contraindications

Known hypersensitivity to the product.


Go to top of the page
4.4 Special warnings and precautions for use

Avoid application to moist or broken skin.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

Aquadrate may increase the penetration through the skin barrier of other topically applied medicaments.


Go to top of the page
4.6 Pregnancy and lactation

Animal reproduction studies have not been conducted with Aquadrate. Aquadrate should only be used if the anticipated benefits outweigh the risks.


Go to top of the page
4.7 Effects on ability to drive and use machines

Aquadrate does not interfere with the ability to drive or use machines.


Go to top of the page
4.8 Undesirable effects

May cause local irritations (including erythema, burning or pruritus) and oedema when applied to sensitive skin. If the condition is aggravated or there is no improvement, the doctor should be consulted.


Go to top of the page
4.9 Overdose

Topical applications of excessive amounts of Aquadrate might cause skin irritation but no other effects would be expected. Ingestion of a large amount of Aquadrate would be expected to result in gastrointestinal irritation (nausea and vomiting). Symptomatic and supportive care should be given. Liberal oral administration of milk or water may be helpful.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Urea acts as a hydrating and keratolytic agent.


Go to top of the page
5.2 Pharmacokinetic properties

Urea is primarily excreted in the urine. A small amount is also eliminated in sweat.


Go to top of the page
5.3 Preclinical safety data

In man, doses of up to 80g/day iv or 100g/day p.o urea are considered safe.

Whilst only very limited preclinical data is available, there is no evidence to suggest that urea would have teratogenic, carcinogenic or mutagenic potential in therapeutic use.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipient(s)

The cream also contains:

White soft paraffin

Maize starch

Isopropyl myristate

Glyceryl tribehenate

Palmitic acid

Sorbitan laurate

Polyoxyethylene fatty glyceride.


Go to top of the page
6.2 Incompatibilities

Not applicable.


Go to top of the page
6.3 Shelf life

Three years.


Go to top of the page
6.4 Special precautions for storage

Do not store above 30°C.


Go to top of the page
6.5 Nature and contents of container

Aquadrate is available in tubes of 30g and 100g.

Not all pack sizes may be marketed.


Go to top of the page
6.6 Special precautions for disposal and other handling

No special requirements.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Alliance Pharmaceuticals Limited

Avonbridge House

Bath Road

Chippenham

Wiltshire SN15 2BB

United Kingdom


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PA 943/5/1


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

Date of First Authorisation:

07 January 1975

Date of Last Renewal:

07 January 2010


Go to top of the page
10. DATE OF REVISION OF THE TEXT

April 2010



Link to this document from your website:
http://www.medicines.ie/medicine/4809/SPC/Aquadrate+10++w+w+Cream/

Document Links

 
  Link to this page
  View all medicines
from this company
Print this page
View document history
Bookmark and Share

Legal Categories

 
   Product subject to medical
prescription which may not
be renewed (A)
   Product subject to medical
prescription which may
be renewed (B)
   Product subject to
restricted prescription
(C)
   Supply through
general sale
   Supply through
pharmacy only

Active Ingredients

 
   Urea

  • Terms & Conditions | 
  • Accessibility | 
  • Privacy Statement | 
  • Contact Us

Registered Address: Franklin House, 140 Pembroke Road, Dublin 4, Ireland
Registered Number: 254776
Tel: (353 1) 6603350 Fax: (353 1) 6686672 Email: info@ipha.ie

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information: verify here.

logo